Table 3. Y haplogroup distributions of the NOA patients and the normal controls.
Y Haplogroup | sub-lineage | NOA | Normal | P value* |
---|---|---|---|---|
J | 2(0.3%) | 2(0.3%) | 1 | |
T | 1(0.1%) | 0 | 1 | |
N | 45(7.6%) | 34(6.0%) | 2.9 × 10−1 | |
Q | 28(4.8%) | 16(2.8%) | 9.2 × 10−2 | |
C | 63(10.7%) | 47(8.3%) | 1.6 × 10−1 | |
D | 10(1.7%) | 14(2.5%) | 4.1 × 10−1 | |
R | 2(0.3%) | 5(0.9%) | 2.8 × 10−1 | |
G | 0 | 1(0.2%) | 4.9 × 10−1 | |
O | O2* | 0 | 9(1.6%) | 1.6 × 10−3 |
O3a | 394(66.9%) | 388(68.2%) | 6.6 × 10−1 | |
O2a | 41(7.0%) | 42(7.4%) | 8.2 × 10−1 | |
O2b | 2(0.3%) | 4(0.7%) | 4.4 × 10−1 | |
O1a2 | 1(0.2%) | 7(1.2%) | 3.5 × 10−2 | |
total | 589 | 569 |
*Fisher’s exact test, one sided.